Skip to content

Pregnancy vitamin D showed no clear maternal bone-density advantage

Mothers assigned vitamin D during pregnancy had no statistically clear bone-density advantage over placebo after delivery or years later, despite higher vitamin D levels in late pregnancy.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Vitamin D supplementation increased mothers' blood vitamin D levels in late pregnancy, but did not produce statistically clear differences in bone mineral density compared with placebo after delivery or several years later. Bone mineral density measures mineral content in bone. These results concern mothers' bone density, and do not establish effects on fractures or other health outcomes.

Keep in mind

This was a post hoc analysis. The abstract gives no confidence intervals for bone-density differences and reports bone density rather than fractures, leaving small effects and clinical outcomes uncertain.

THE RESULT, WITH CONTEXT

What researchers found

No statistically clear bone-density difference

Maternal bone mineral density

Vitamin D versus placebo at whole-body, spine and left-hip sites, within 2 weeks and around 4 years after delivery; all between-group tests had p > 0.05.

Osteoporos Int, 2025 · Original source ↓

Blood levels and bone measurements

The supplement changed a blood marker of vitamin D status, but that change did not translate into a demonstrated difference in the measured bone-density outcomes. The blood marker and bone scans answer different questions.

What the null finding means

Similar bone-density results were reported at both assessments and in the repeated-measures analysis. A nonsignificant comparison does not prove identical effects, especially when the abstract does not provide confidence intervals for the differences.

CHECK THE ORIGINAL

The original publication

Pregnancy vitamin D supplementation and bone mineral density of the mother: a post hoc analysis of the MAVIDOS randomised placebo-controlled trial.

Moon RJ, D'Angelo S, Curtis EM et al.
Osteoporos Int · 2025

PubMed ID
40549003
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.